Political influence ‘a serious problem’ for FDA under Trump, former commissioner says

Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if government regulators handle the new therapeutics properly. At least that’s how Robert…
Source
Stat News
Opens original article in a new tab


